| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | Evans Daron CFO | Purchase | +10,000 | +2.47%414,462 | $2.85 | $28,500 | View SEC filing | |
| 2025-12-17 | Hogenhuis Wladimir Director | Purchase | +5,650 | +4.96%119,675 | $1.69 | $9,549 | View SEC filing | |
| 2025-12-17 | ROBERTS BRIAN KENNETH Chief Medical Officer | Purchase | +28,000 | +9.99%308,352 | $1.70 | $47,600 | View SEC filing | |
| 2025-12-15 | Evans Daron CFO | Purchase | +45,000 | +11.69%429,900 | $1.77 | $79,578 | View SEC filing | |
| 2025-12-15 | Elam Nevan C CEO | Purchase | +32,000 | +5.25%641,119 | $1.59 | $50,880 | View SEC filing | |
| 2025-12-15 | Karnawat Sunil Ratilal Chief Commercial Officer | Purchase | +12,100 | +20.36%71,542 | $1.62 | $19,599 | View SEC filing | |
| 2025-06-26 | ROBERTS BRIAN KENNETH Chief Medical Officer | Purchase | +2,500 | +19.23%15,500 | $4.38 | $10,939 | View SEC filing | |
| 2025-06-24 | Evans Daron CFO | Purchase | +5,000 | +1.89%268,900 | $4.05 | $20,250 | View SEC filing | |
| 2025-06-23 | Kim Young-Jin Director | Purchase | +1,230,769 | +17.11%8,423,386 | $3.25 | $3,999,999 | View SEC filing | |
| 2025-06-23 | KREHER NERISSA Director | Purchase | +3,076 | +8.92%37,576 | $3.25 | $9,997 | View SEC filing | |
| 2025-04-01 | Hogenhuis Wladimir Director | Purchase | +6,758 | +8.75%84,025 | $2.92 | $19,733 | View SEC filing | |
| 2025-03-31 | Elam Nevan C CEO | Purchase | +12,302 | +5.81%224,119 | $2.85 | $34,999 | View SEC filing | |
| 2025-03-28 | Evans Daron CFO | Purchase | +20,000 | +8.30%260,900 | $2.88 | $57,700 | View SEC filing | |
| 2025-02-20 | Hogenhuis Wladimir Director | Purchase | +10,000 | +14.87%77,267 | $4.70 | $47,000 | View SEC filing | |
| 2025-02-19 | Kim Young-Jin Director | Purchase | +1,250,000 | +21.03%7,192,617 | $4.00 | $5,000,000 | View SEC filing | |
| 2024-12-18 | Evans Daron CFO | Purchase | +10,000 | +7.10%150,900 | $4.29 | $42,900 | View SEC filing | |
| 2024-12-12 | Evans Daron CFO | Purchase | +9,000 | +6.82%140,900 | $4.60 | $41,400 | View SEC filing | |
| 2024-12-10 | Evans Daron CFO | Purchase | +10,549 | +8.69%131,900 | $5.04 | $53,167 | View SEC filing | |
| 2024-09-24 | Hogenhuis Wladimir Director | Purchase | +4,259 | +11.35%41,767 | $4.70 | $20,017 | View SEC filing | |
| 2024-06-27 | Hogenhuis Wladimir Director | Purchase | +4,815 | +14.73%37,508 | $4.15 | $19,982 | View SEC filing | |
| 2024-06-14 | ROBERTS BRIAN KENNETH Chief Medical Officer | Purchase | +7,600 | +12.43%68,728 | $3.91 | $29,743 | View SEC filing | |
| 2024-06-14 | Evans Daron CFO | Purchase | +40,000 | +100.00%40,000 | $4.04 | $161,568 | View SEC filing | |
| 2024-05-31 | Evans Daron CFO | Purchase | +451 | +0.37%121,351 | $3.50 | $1,579 | View SEC filing | |
| 2024-05-28 | ROBERTS BRIAN KENNETH Chief Medical Officer | Purchase | +7,500 | +17.63%50,052 | $2.69 | $20,138 | View SEC filing | |
| 2024-05-28 | Evans Daron CFO | Purchase | +3,000 | +30.00%13,000 | $3.22 | $9,668 | View SEC filing |
1-25 of 106
